Genetic Characteristics and Range of Antibacterial Activity of the Bacteriophages, which are a Part of Manufactured Serie of Drugs - Pyobacteriophage Polyvalent Purified

Genetic Characteristics and Range of Antibacterial Activity of the Bacteriophages, which are a Part of Manufactured Serie of Drugs - Pyobacteriophage Polyvalent Purified

Pyobacteriophage polyvalent cleared (preparation) is active against 85.0 - 99.6% clinical strains of bacteria Proteus spp., Streptococcus spp., Klebsiella pneumoniae, Escherichia coli, Staphylococcus spp., and Pseudomonas aeruginosa. The preparation surpasses the majority of antibiotics in the width...

Full description

Bibliographic Details
Main Authors:	N. V. Tikunova, N. N. Voroshilov, O. A. Polygach, V. V. Morozova, A. Y. Tikunov, A. M. Smokers, V. V. Vlasov
Format:	Article
Language:	Russian
Published:	Numikom LLC 2016-04-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	бактерии бактериофаги антибиотики антибактериальная активность токсичность побочные реакции bacteria bacteriophages antibiotics toxicity antibacterial activity side effects
Online Access:	https://www.epidemvac.ru/jour/article/view/156

Similar Items

Modern Approaches to the Methods of Creating of Phage Basis for Treatment-Prophylactic a Drug of Bacteriophages Pseudomonas aeruginosa
by: O. A. Polygach, et al.
Published: (2018-04-01)

Effect of the Composition of Lytic Bacteriophages of P. aeruginosa Formation and Destruction of Bacterial Biofilms
by: O. A. Polygach, et al.
Published: (2018-09-01)

Adaptive Phage Therapy in the Treatment of Patients with Recurrent Pneumonia (Pilot Study)
by: N. V. Beloborodova, et al.
Published: (2021-12-01)

Adverse reactions of high-osmolar and low-osmolar radiographic contrast media in clinical practice
by: G. A. Batischeva, et al.
Published: (2023-03-01)

Bacteriophages: present and future aspects of use
by: S. M. Zakharenko
Published: (2013-12-01)

Increasing efficiency of antibiotic therapy with the help of proteolytic enzymes
by: N. A. Malyshev, et al.
Published: (2013-12-01)

Contraindications and adverse events of drugs in cardioneurological patients.
by: Ol'ga Gennadievna Kompaniets
Published: (2009-09-01)

Nephrotoxic characteristics of anti-tuberculosis drugs
by: G. N. Mozhokina, et al.
Published: (2019-11-01)

Сравнительный анализ чувствительности методов биотестирования токсичности тяжелых металлов
by: Игнатенко А. В.
Published: (2018-01-01)

THE SAFETY AND EFFICACY OF RIFAPENTINE USED TO TREAT DRUG-SUSCEPTIBLE PULMONARY TUBERCULOSIS
by: N. V. Litvinova, et al.
Published: (2014-04-01)

Ratsional'naya antibiotikoterapiya i antibiotikoprofilaktika v ginekologii
by: A L Tikhomirov, et al.
Published: (2007-06-01)

Modern approach to antibacterial therapy in the practice of a surgeon
by: A. M. Morozov, et al.
Published: (2021-05-01)

Changes of approaches to chemotherapy in children of the tender age over 30-year period
by: A. R. Аroyan, et al.
Published: (2018-11-01)

Bacteriophage therapy and prevention of pyelonephritis in pregnant women: practical experience and long-term results
by: Yu. A. Zakharova, et al.
Published: (2013-12-01)

Antibiotics in aquaculture and their ecological significance. A review
by: Lidia V. Shulgina, et al.
Published: (2015-06-01)

Synergistic effect of antitumor activity of doxorubicin and bicomponent nanostructures based on aluminum oxide
by: O. V. Bakina, et al.
Published: (2020-04-01)

Selection criteria for bacterial strains and bacteriophages for the formation of industrial collection of specifically lysing bacteria: <i>Klebsiella, Echerichia, Proteus, Pseudomonas, Staphylococcus</i>
by: E. N. Siatchikhina, et al.
Published: (2018-02-01)

КАК ПЕПТИДЫ-АНТИБИОТИКИ ВЗАИМОДЕЙСТВУЮТ С МИКРООРГАНИЗМАМИ
by: Юрий Владимирович Дадали, et al.
Published: (2020-08-01)

SYNTHESIS AND ACARICIDAL, BACTERIOSTATIC ACTIVITY AMONG THE AMINO DERIVATIVES 5,7-DICHLORO-4,6-DINITROBENZOFUROXANA
by: L. V. Spatlova, et al.
Published: (2019-01-01)

PROFILE AND RISK FACTORS OF ADVERSE REACTIONS IN NEW TUBERCULOSIS CASES RECEIVING TREATMENT
by: D. A. Ivаnovа, et al.
Published: (2017-06-01)

Antibiotic Prophylaxis of Infective Endocarditis: From the History of the Concept to Modern Recommendations (Review)
by: G. G. Taradin, et al.
Published: (2020-03-01)

АНТИБАКТЕРИАЛЬНАЯ ТЕРАПИЯ ИНФИЦИРОВАННОГО ПАНКРЕОНЕКРОЗА: СОСТОЯНИЕ ПРОБЛЕМЫ И ПЕРСПЕКТИВЫ
Published: (2018-01-01)

SUCCINIC ACID PREPARATIONS IN THE COMBINATION TREATMENT OF PATIENTS WITH TUBERCULOSIS
by: A. V. Mordykh, et al.
Published: (2014-06-01)

Some safety aspects of a new russian pegylated interferon-A medication “ALGERON” (phase 1 clinical trial)
by: A I Tukach, et al.
Published: (2014-12-01)

BIOLOGICAL ACTIVITY OF HYDROGENALIDES OF AMIDEZONE
by: A. S. Senina, et al.
Published: (2019-01-01)

Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy
by: M M Konstantinova, et al.
Published: (2005-09-01)

The prophylaxis and treatmen to finfectious complications caused by nosoco-mialflora after kidney transplantation from living related donor
by: E. P. Volynchik, et al.
Published: (2018-08-01)

Features of application of raltegravir in HIV-infected patients with different somatic pathologies
by: N. V. Sizova, et al.
Published: (2021-10-01)

Synthesis, Acaricidal, Bacteriostatic Activity Among the Amino Derivatives 5,7-Dichloro-4,6-Dinitrobenzofuroxana
by: L. V. Spatlova
Published: (2019-05-01)

Frequency and characteristics of adverse events caused by anti-tuberculosis drugs in pulmonary tuberculosis patients with diabetes myelitis
by: O. G. Komissarova, et al.
Published: (2020-03-01)

Combined modality radiotherapy for high-risk prostate cancer. Analysis of treatment-Related complications
by: K. S. Makarova, et al.
Published: (2019-04-01)

Dynamics of the Content of Lactobacilli, Microbial Metabolites and Antimicrobial Activity of Growing Culture of Lactobacillus Plantarum 8P-A3
by: I. Yu. Chicherin, et al.
Published: (2014-09-01)

Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis
by: O. V. Filinyuk, et al.
Published: (2022-10-01)

Побочные эффекты противоэпилептических препаратов второго поколения
Published: (2018-06-01)

Основные механизмы развития неблагоприятных побочных реакций
Published: (2018-06-01)

HEMATOTOXIC ADVERSE DRUG REACTIONS ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS AND CYTOTOXIC DRUGS IN THE TREATMENT OF GLIOBLASTOMA: A SYSTEMATIC REVIEW
by: I. A. Stepanov, et al.
Published: (2020-10-01)

BIOLOGICAL ACTIVITY OF HYPERICUM PERFORATUM L. (HYPERICACEAE): A REVIEW
by: A. L. Budantsev, et al.
Published: (2021-06-01)

THE STUDY THE EFFICACY AND SAFETY OF ANTIMICROBIAL AGENTS
by: V. V. Bagaeva, et al.
Published: (2015-10-01)

Tolerability of individual chemotherapy regimens in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkinа, et al.
Published: (2021-04-01)

Drug induced skin reactions characteristics in multifield emergency hospital
by: M Ya Rudyk, et al.
Published: (2012-03-01)